Compare MDAI & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDAI | HYFT |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | United States |
| Employees | 65 | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.0M | 56.5M |
| IPO Year | 2021 | 2017 |
| Metric | MDAI | HYFT |
|---|---|---|
| Price | $1.52 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | ★ $5.11 | $4.33 |
| AVG Volume (30 Days) | 110.0K | ★ 253.8K |
| Earning Date | 11-10-2026 | 12-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,650,000.00 | N/A |
| Revenue This Year | N/A | $12.86 |
| Revenue Next Year | $74.98 | $22.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.18 | $0.99 |
| 52 Week High | $2.97 | $3.00 |
| Indicator | MDAI | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 34.89 |
| Support Level | $1.42 | $1.03 |
| Resistance Level | $1.48 | $1.50 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 36.00 | 16.34 |
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.